ArticleFrontiers in artificial intelligence2020
Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence.
Article in Frontiers in artificial intelligence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05651282 (Uterine Cancer Risk Reducing Strategies in Postmenopausal Women), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Uterine Cancer Risk Reducing Strategies in Postmenopausal Women
Who cites it
18 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Insights and limitations of endometrial cancer risk prediction models for clinical applicability: a systematic review.BMC cancer · 2025Pooled it
- Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review.Advances in nutrition (Bethesda, Md.) · 2025Pooled it
- Diagnosis Test Accuracy of Artificial Intelligence for Endometrial Cancer: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2025Pooled it
- Review
- Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies.International journal of clinical oncology · 2026Review
- Comparing self-reported race and genetic ancestry for identifying potential differentially methylated sites in endometrial cancer: insights from African ancestry proportions using machine learning models.Molecular oncology · 2025Article
- Review
- Impact of artificial intelligence on the diagnosis, treatment and prognosis of endometrial cancer.Annals of medicine and surgery (2012) · 2024Review
- Machine learning based models for predicting presentation delay risk among gastric cancer patients.Frontiers in oncology · 2024Article
- Advancing Patient Care: How Artificial Intelligence Is Transforming Healthcare.Journal of personalized medicine · 2023Review
- Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm.Frontiers in artificial intelligence · 2023Review
- Interpretable prognostic modeling of endometrial cancer.Scientific reports · 2022Article
- The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review.Journal of medical Internet research · 2022Article
- Statistical biopsy: An emerging screening approach for early detection of cancers.Frontiers in artificial intelligence · 2022Article
- Machine Learning for Endometrial Cancer Prediction and Prognostication.Frontiers in oncology · 2022Review
- Research on the Guiding Effect of CTCs on Postoperative Adjuvant Therapy for Patients with Early Stage Endometrial Cancer.Journal of oncology · 2022Article
- Prediction of Endometrial Carcinoma Using the Combination of Electronic Health Records and an Ensemble Machine Learning Method.Frontiers in medicine · 2022Article
- Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers.Cancers · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Incidence and mortality rates of endometrial cancer are increasing, leading to increased interest in endometrial cancer risk prediction and stratification to help in screening and prevention. Previous risk models have had moderate success with the area under the curve (AUC) ranging from 0.68 to 0.77. Here we demonstrate a population-based machine learning model for endometrial cancer screening that achieves a testing AUC of 0.96. We train seven machine learning algorithms based solely on personal health data, without any genomic, imaging, biomarkers, or invasive procedures. The data come from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). We further compare our machine learning model with 15 gynecologic oncologists and primary care physicians in the stratification of endometrial cancer risk for 100 women. We find a random forest model that achieves a testing AUC of 0.96 and a neural network model that achieves a testing AUC of 0.91. We test both models in risk stratification against 15 practicing physicians. Our random forest model is 2.5 times better at identifying above-average risk women with a 2-fold reduction in the false positive rate. Our neural network model is 2 times better at identifying above-average risk women with a 3-fold reduction in the false positive rate. Our machine learning models provide a non-invasive and cost-effective way to identify high-risk sub-populations who may benefit from early screening of endometrial cancer, prior to disease onset. Through statistical biopsy of personal health data, we have identified a new and effective approach for early cancer detection and prevention for individual patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.